Inmune Bio's total assets for Q1 2025 were $37.80M, a decrease of -4.45% from the previous quarter. INMB total liabilities were $8.13M for the fiscal quarter, a 8.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.